Immuno US Incorporated in San Diego, CA

Company Name: Immuno US Incorporated

Street: 16885 Via Del Campo Ct

City: San Diego

State: CA

Postal Code: 92127

Address: 16885 Via Del Campo Ct, San Diego, CA, 92127

Explore More Information
  1. Immuno-oncology: the future of cancer therapy? | Rathbones
    John McDougall, from Rathbones’ research team, gives an overview of immuno-oncology, an exciting area of pharmaceutical research that could have a major impact on ...
  2. Baxalta and Precision BioSciences form Global Genome ...
    Baxalta and Precision BioSciences form Global Genome Editing Collaboration in Immuno-Oncology
  3. BD Diagnostics - TriPath Cervical Cytology Products
    BD Diagnostics - TriPath offers products for cervical cytology screening, such as the BD SurePath™ liquid-based Pap test.
  4. Immuno Concepts — Diagnostic Assays for Systemic Rheumatic ...
    Diagnostic Assays for Systemic Rheumatic Diseases ... Positive SSA patient Sample. Did you know that among patients eventually diagnosed with SLE, 47% had anti-SSA/Ro ...
    Immuno Multi is a multivitamin/ mineral /antioxidant for the maintenance of good health and a source of antioxidants to maintain healthy immune system function.
  6. Celt Naturals IMMUNO-CARE - 60 CAPS + BONUS ITEM
    Get Celt Naturals IMMUNO-CARE - 60 CAPS + BONUS ITEM @ National Nutrition. Read customer reviews, product info & suggested uses. ** OVER 40% OFF REGULAR PRICE **
  7. Readmore - symphogen
    Baxalta Incorporated (NYSE: BXLT), a global biopharmaceutical leader dedicated to delivering transformative therapies to patients with orphan diseases and underserved ...
  8. Azathioprine - Wikipedia, the free encyclopedia
    Azathioprine (AZA), also known by its brand name Imuran, is an immunosuppressive drug used in organ transplantation and autoimmune diseases and belongs to the ...
  9. Baxalta and Symphogen Establish Strategic Collaboration to ...
    Baxalta and Symphogen establish strategic collaboration to accelerate innovation in immuno-oncology
  10. Celgene/AstraZeneca Start Immuno-Oncology Drug Studies ...
    Celgene Corporation (CELG - Analyst Report) and AstraZeneca (AZN - Analyst Report) announced the initiation of the FUSION development program on investigational human ...

Pages: 1 2

Related Companies